Neurotoxin

Merz Strengthens Partnership With Start-up Vensica and Invests up to $3 million

Retrieved on: 
Monday, February 7, 2022
Health, Pharmaceutical, Liver disease, Pain, Israel Innovation Authority, Overactive bladder, Growth, Culture, Yale University, Multimedia, SGX, Research, Solution, Investment, II, Therapy, Merz, Nocturnal penile tumescence, Urinary retention, UK Financial Investments, Patient, Merz Aesthetics Women's Challenger, Neurotoxin, DNA, CEO, Workforce, Interstitial cystitis, IBF, Movement disorders, Partnership, Pharmaceutical industry, Medical device, Merz Therapeutics, Vensica Therapeutics, Merz, MERZ THERAPEUTICS, VENSICA THERAPEUTICS, MERZ

Merz Therapeutics, a company of the Merz Group and a leader in the field of neurotoxins, is expanding its strategic partnership with Vensica Therapeutics as the Merz Group invests up to $3 million in the Israeli start-up.

Key Points: 
  • Merz Therapeutics, a company of the Merz Group and a leader in the field of neurotoxins, is expanding its strategic partnership with Vensica Therapeutics as the Merz Group invests up to $3 million in the Israeli start-up.
  • Vensica is expanding its workforce in Israel for next stage clinical and regulatory development of its device together with Merz Therapeutics XEOMIN, focusing on overactive bladder treatment.
  • Merz commitment to Vensica reflects how promising the needleless treatment of patients with overactive bladder is in combination with our strategic product XEOMIN.
  • Merz Group has the businesses Merz Aesthetics, Merz Therapeutics, Merz Consumer Care, Merz Real Estate and Financial Investments.

Global Muscle Spasticity Market (2021 to 2028) - by Drug Type, Route of Administration, Distribution Channel and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, February 4, 2022
Pharmaceutical, Health, Other Health, MHLW, Route of administration, Amyotrophic lateral sclerosis, Ministry, Occupational therapy, Spasticity, ALS, List of health departments and ministries, Diazepam, Neurotoxin, Muscle, Goal, MS, Sleep, Administration, Market share, Brain, Pain, Region, Baclofen, Common, Toxin (comics), Multiple sclerosis, Pharmaceutical industry, Health

The "Muscle Spasticity Market, by Drug Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Muscle Spasticity Market, by Drug Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • When muscles become stiff or contract, the condition is called as muscle spasticity.
  • Muscle spasticity is seen in a variety of conditions such as spinal cord injury, brain injury, diseases such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).
  • The increasing launches of new drugs and regulatory approvals for muscle spasticity are expected to drive the market growth during the forecast period.

DETOXIFY YOUR PERSONAL CARE REGIMEN WITH THE NATURAL GROCERS® BODY CARE & BEAUTY BONANZA IN FEBRUARY 2022

Retrieved on: 
Monday, January 24, 2022
Honey, Vitamin, Face, Research, Vitamin Cottage Natural Grocers, JASON, Policy, Man, Skin care, Fertility, Carcinogen, NYSE, Neurotoxin, Tax, Running, Health, Woman, Dietary supplement, Privacy, Beauty, View, Soap bar, Honeypot, Company, Multimedia, Hand, District, Cosmetics, Worshipful Company of Grocers, Nutrition education, Nature, USDA, Awareness, Beauty salon, Grocery store, Online gambling, Weleda

To help its communities detoxify their beauty and hygiene routines, Natural Grocers is hosting its 2nd annual Body Care & Beauty Bonanza all February long.

Key Points: 
  • To help its communities detoxify their beauty and hygiene routines, Natural Grocers is hosting its 2nd annual Body Care & Beauty Bonanza all February long.
  • Over 150 brands have passed the test of Natural Grocers' 'What We Won't Carry and Why' standards.
  • {N}power members will receive an automatic entry for every $50 spent on body care and beauty products from January 28 through February 26iii.
  • Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is an expanding specialty retailer of natural and organic groceries, body care products, and dietary supplements.

Dermatologist Dr. Cybele Fishman of Advanced Dermatology Provides Tips on Alternative Uses for Botox®

Retrieved on: 
Thursday, January 20, 2022
Muscle, Patient, Allergan, Inc., Migraine, Eye, Mouth, Injection, Exercise, Scalp, Hyperhidrosis, Suite, AbbVie, Neurotoxin, Death, American Academy, Physician, Continuum, BOTOX, Center, Neck pain, Skin, Eyebrow, Paralysis, Goal, Smart contract, Plastic surgery, Perspiration, Head, Forehead, Genetics, Spasms, Neck, MD, Muscular system, Botulism, Torticollis, Headache, Exocrine gland, American Academy of Dermatology, Cosmetics, Pharmaceutical industry, Dermatology

Botox acts on muscle cells and, as we've learned over time, there are almost endless applications for its beneficial effects."

Key Points: 
  • Botox acts on muscle cells and, as we've learned over time, there are almost endless applications for its beneficial effects."
  • "There are many more proven uses for Botox," says Dr. Fishman.
  • Dr. Fishman also advises to be careful of Med Spas where Botox is offered very inexpensively.
  • Cybele Fishman, MD , is a board-certified dermatologist, a fellow of the American Academy of Dermatology.

Marie V. Hayag, M.D. Brings Elite New York City Cosmetic Dermatology Practice to Palm Beach

Retrieved on: 
Tuesday, January 11, 2022
Face, Patient, Science, Goal, Neurotoxin, Maintenance, Fifth Avenue, PALM, Environment, Awareness, Interior design

is bringing her premier cosmetic dermatology business to Palm Beach.

Key Points: 
  • is bringing her premier cosmetic dermatology business to Palm Beach.
  • The uniquely incredible experience and progressive techniques showcased at Dr. Hayag's Fifth Avenue, New York City office, Fifth Avenue Aesthetics, can now be found in the sunny shores of Palm Beach with her latest extension.
  • The expansion comes off the successful and incredibly popular New York City flagship, Fifth Avenue Aesthetics, located at 875 Fifth Avenue in Manhattan.
  • The new Florida offices can be found at 185 Banyan Boulevard, West Palm Beach, FL 33401.

Medical Spa Show 2022 Presents Unprecedented Gathering of Medical Aesthetics Superstars

Retrieved on: 
Wednesday, November 17, 2021
Skin, Wynn Las Vegas, Industry, Face, Health, Miller, Dermatology, American Academy of Facial Plastic and Reconstructive Surgery, MSS, Speech, Cadaver, Breast, Anatomy, American Board of Otolaryngology, DNP, JD, Life & Style, Gonzaga University, UCLA, GEN, CME, Marketing, Neurotoxin, American Board of Commissioners for Foreign Missions, CBS, Day, Academy, Keynote, Television, Rhinoplasty, FNP, FACS, Life, American Academy, Beauty salon, Dentistry

Dr. Kirby's popular reputation, coupled with his medical and business expertise, make him the perfect choice to present the keynote speech at the fifth annual Medical Spa Show."

Key Points: 
  • Dr. Kirby's popular reputation, coupled with his medical and business expertise, make him the perfect choice to present the keynote speech at the fifth annual Medical Spa Show."
  • The Medical Spa Show, presented by the American Med Spa Association (AmSpa), is the premier trade show for medical spas and non-invasive medical aesthetics, and it will take place from January 28 30, 2022, at Wynn Las Vegas, with pre-event education taking place on Thursday, January 27.
  • He operates a medical practice in Beverly Hills, California, and medical spas in Beverly Hills and Manchester, U.K.
  • These medical aesthetics all-stars will also be appearing at MSS 2022:

Acumen Pharmaceuticals Reports Financial Results for Third Quarter 2021 and Business Highlights

Retrieved on: 
Monday, November 15, 2021
Safety, Neuron, Mab, Private Securities Litigation Reform Act, AD, Cohort, Clinical trial, R, ABOS, NASDAQ, Series, Security (finance), Research and development, SAD, COVID-19, Goal, Research, Administration, No net loss wetlands policy, Forward-looking statement, NCT, U.S. Securities and Exchange Commission, GLOBE, IPO, SEC, Therapy, Initial public offering, Pharmacokinetics, Cash balance plan, Neurotoxin, Neurodegeneration, Pathology, MAD, Patient, Pharmaceutical industry, Animal

Starting with our successful IPO in early July, the third quarter of 2021 marked the beginning of the next phase of life for our company.

Key Points: 
  • Starting with our successful IPO in early July, the third quarter of 2021 marked the beginning of the next phase of life for our company.
  • In October 2021, we announced the screening and initial dosing of our first patient in INTERCEPT-AD, said Daniel OConnell, President and Chief Executive Officer at Acumen.
  • We have cleared our sentinel safety review and are continuing to recruit patients in INTERCEPT-AD.
  • Acumen Pharmaceuticals, headquartered in Charlottesville, VA, with clinical operations based in Carmel, IN, is a clinical stage biopharmaceutical company developing a novel disease-modifying approach to treat Alzheimers disease.

SCA Welcomes Chloe Goldman, MD!

Retrieved on: 
Friday, November 5, 2021
The arts, Practice management, University, Cornell University, Rockefeller University, MIAMI, Skin, SCA, Chief resident, Elective surgery, Partnership, Board, CAPP, Company, Neurotoxin, Skin care, College of Arts and Sciences, Laser, Patient, Medical device

MIAMI GARDENS, Fla., Nov. 5, 2021 /PRNewswire/ -- Skin and Cancer Associates (SCA) is pleased to welcome Chloe Goldman, MD to our dermatology group.

Key Points: 
  • MIAMI GARDENS, Fla., Nov. 5, 2021 /PRNewswire/ -- Skin and Cancer Associates (SCA) is pleased to welcome Chloe Goldman, MD to our dermatology group.
  • Born and raised in New York City, Dr. Goldman obtained her undergraduate degree from Cornell University, College of Arts & Sciences.
  • Following Cornell, Dr. Goldman worked in scientific research at The Rockefeller University and thereafter attended medical school at New York University.
  • Founded in the early 70's and headquartered in the Miami, Florida area, SCA is a partnership of over 30 dermatology practices.

Optima Dermatology Now Open in Macedonia

Retrieved on: 
Thursday, November 4, 2021
Aurora, Health, Family, Learning, Dermatology, Skin cancer, PRP, MD, Friends, Psoriasis, Acne, HA, FAAD, NP-C, Neurotoxin, Skin care, Dermatitis, Patient, Veterinary medicine, Hospital

MACEDONIA, Ohio, Nov. 4, 2021 /PRNewswire/ -- Optima Dermatology is pleased to announce its new practice in Macedonia is now open and accepting patients.

Key Points: 
  • MACEDONIA, Ohio, Nov. 4, 2021 /PRNewswire/ -- Optima Dermatology is pleased to announce its new practice in Macedonia is now open and accepting patients.
  • Optima Dermatology is proud to be expanding convenient access to expert dermatology care in Ohio and takes great pride in providing an exceptional experience at each practice.
  • Optima Dermatology's industry-leading, board-certified dermatologists and providers treat a broad range of medical dermatology conditions and diseases, including skin cancer, eczema, acne, psoriasis, and more.
  • In addition to general dermatology, Optima Dermatology offers cosmetic services, including neurotoxin injections (such as Botox and Dysport), fillers, and more.

Acumen Pharmaceuticals to Present Clinical Trial Design for INTERCEPT-AD, the Phase 1 Placebo-Controlled, Single- and Multiple-Dose Clinical Trial of ACU193, at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Retrieved on: 
Tuesday, November 2, 2021
Safety, SAD, MAD, ABOS, Research, Neurotoxin, Goal, ARIA, NCT, Neuron, Mab, Pathology, Amyloid-related imaging abnormalities, Security (finance), U.S. Securities and Exchange Commission, Patient, Private Securities Litigation Reform Act, NASDAQ, SEC, Brain, Forward-looking statement, Synapse, Clinical trial, Neurodegeneration, COVID-19, Cognition, AD, Pharmacokinetics, Cell death, Therapy, GLOBE, Pharmaceutical industry, Vaccine

CHARLOTTESVILLE, Va. and CARMEL, Ind., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage biopharmaceutical company focused on the development of novel targeted therapeutics for Alzheimer’s disease (AD), today announced the company will deliver an oral presentation on the clinical trial framework of its product candidate, ACU193, at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) conference, being held in-person and virtually November 9-12 in Boston. ACU193 is a monoclonal antibody that selectively targets toxic soluble amyloid-beta oligomers (AβOs) for the treatment of early Alzheimer’s disease.

Key Points: 
  • ACU193 is a monoclonal antibody that selectively targets toxic soluble amyloid-beta oligomers (AOs) for the treatment of early Alzheimers disease.
  • We believe that oligomer-specific therapeutics are less likely to result in amyloid-related imaging abnormalities or ARIA a major safety concern for plaque-targeting drugs.
  • Acumen Pharmaceuticals, headquartered in Charlottesville, Va. with clinical operations based in Carmel, Ind., is a clinical stage biopharmaceutical company developing a novel disease-modifying approach to treat Alzheimers disease.
  • Additional information will be made available in other filings that Acumen makes from time to time with the SEC.